Doctor Samuel Adamsson Eryd

AstraZeneca, Gothenburg (Sweden)

Follow

Contributor content

Early treatment of heart failure: a non-interventional observational study programme of patients with heart failure and initiated on dapagliflozin (EVOLUTION HF)

Presentation

Early treatment of heart failure: a non-interventional observational study programme of patients with heart failure and initiated on dapagliflozin (EVOLUTION HF)

ESC 365 is supported by

novartis

Explore sponsored resources